Publication | Closed Access

Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study

Petacc 3Surgical OncologyGastrointestinal OncologyMedicineCancer ManagementGastroenterologyColorectal CancerChemotherapy Dose ReductionObese PatientsSurgeryCancer TreatmentOncologyRadiation Oncology